Milam 15mg tablets contain the active ingredient midazolam, a short-acting medication belonging to the benzodiazepine class. It works by enhancing the effects of GABA, a natural neurotransmitter that calms the central nervous system.
Because it is a potent sedative, Milam is heavily regulated. In Kenya, it is classified as a controlled prescription item under the Pharmacy and Poisons Board and can only be dispensed with a valid medical prescription.
Primary Uses
-
Preoperative Sedation: Taken shortly before surgeries or diagnostic medical procedures to relieve anxiety, induce relaxation, and cause temporary short-term memory loss (amnesia) so the patient does not remember the procedure discomfort.
-
Short-Term Insomnia: Prescribed occasionally for severe, acute sleep disturbances, though typically restricted to short-term clinical use due to the risk of dependency.
Common Side Effects
- Daytime drowsiness and fatigue
- Muscle weakness and poor coordination
- Headaches and confusion
-
Critical Risk: It can cause respiratory depression (slowed breathing), which means it must be used with extreme caution.
Key Contraindications
Milam 15mg tablets should never be used by individuals with:
- Severe breathing difficulties (e.g., severe chronic obstructive pulmonary disease or sleep apnea)
- Severe liver disease
- Myasthenia gravis (a muscle weakness disorder)
- Pregnancy, as it can harm the developing baby.
